The Exchange has sought clarification from Venus Remedies Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has asked Venus Remedies to clarify why its Limited Review Report/Independent Auditor's Report for the quarter ended 30 September 2025 is not in the format prescribed by SEBI under Regulation 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015. The company's response is still awaited. No financial or operational impact has been disclosed at this stage. This appears to be a routine compliance query on the formatting of the audit submission.
This is a procedural compliance matter and is unlikely to materially affect the stock price unless the company fails to respond or the issue escalates. Investors should watch for the company's clarification in the coming days.